A universal respiratory syncytial virus (RSV) immunization program using Sanofi’s Beyfortus (nirsevimab) was associated with ...
Along with efficacy and safety demonstrated in clinical studies, the effectiveness of Beyfortus has been evaluated in more than 50 real-world studies, including more than 400,000 infants who were ...
All countries should offer universal infant immunization for hepatitis B, write Dr. Christopher Mackie from McMaster University and coauthors in a public health ...
WASHINGTON, July 30, 2019 /PRNewswire-PRWeb/ -- The United Nations Foundation's Shot@Life campaign, which helps expand access to life-saving childhood vaccines globally, is proud to share an expanded ...
Researchers at CDDEP recently published 'Improving vaccination coverage and timeliness through periodic intensification of routine immunization: evidence from Mission Indradhanush' where they ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results